Elsevier introduces Embase AI, a GenAI-powered version of Embase, the leading biomedical literature database. Embase AI ...

Built in partnership with the research community to help users more easily discover, analyze, and synthesize research using trusted data powered by responsible AI ...

A scholarly journal run by the Dutch publishing giant Elsevier has come under scrutiny for rejecting a paper submitted for publication because, among other reasons, it didn’t cite enough of the ...

Their boycott grew momentum, at one point amassing 9,000 signatories that promised not to publish their research in a journal owned by Elsevier. At the time, some called the move an “ Academic ...

Scientific publishing giant Elsevier put out a total of six publications between 2000 and 2005 that were sponsored by unnamed pharmaceutical companies and looked like peer reviewed medical journals, ...

New PharmaPendium solution comes with DDI risk calculator enabling earlier and more complete risk mitigation strategies for potential drug-drug interactions Elsevier, the information analytics ...

Elsevier argued that its fee is “competitively below the market average relative to quality.” For instance, Springer, another major publisher, ...

Elsevier is debuting SciBite Chat, a new AI-powered tool built atop SciBite Search platform. SciBite Chat combines the strength of semantic search for accurate and traceable information retrieval ...

Access to Enamine's novel compounds will allow Reaxys users to cut development times and costs by up to 90% London, United Kingdom--(Newsfile Corp. - December 3, 2024) - Elsevier, a global leader ...

Researchers have found that even after recovery, individuals who previously experienced depression may retain a heightened ...